Paloma Partners Management CO Astrazeneca PLC Transaction History

Paloma Partners Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $225,547 - $268,043	-5,312 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $213,117 - $241,536	5,312 New	5,312 $237,000
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $264,176 - $301,872	-7,600 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $56,903 - $61,021	1,647 Added 27.67%	7,600 $267,000
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $196,270 - $218,058	5,953 New	5,953 $208,000

1,359

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $196B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.